Literature DB >> 11084232

BJ: an S-Plus program to fit linear regression models to censored data using the Buckley-James method.

J Stare1, F E Harrell, H Heinzl.   

Abstract

Most researchers are familiar with ordinary multiple regression models, most commonly fitted using the method of least squares. The method of Buckley and James (J. Buckley, I. James, Linear regression with censored data, Biometrika 66 (1979) 429-436.) is an extension of least squares for fitting multiple regression models when the response variable is right-censored as in the analysis of survival time data. The Buckley-James method has been shown to have good statistical properties under usual regularity conditions (T.L. Lai, Z. Ying, Large sample theory of a modified Buckley-James estimator for regression analysis with censored data, Ann. Stat. 19 (1991) 1370-1402.). Nevertheless, even after 20 years of its existence, it is almost never used in practice. We believe that this is mainly due to lack of software and we describe here an S-Plus program that through its inclusion in a public domain function library fully exploits the power of the S-Plus programming environment. This environment provides multiple facilities for model specification, diagnostics, statistical inference, and graphical depiction of the model fit.

Mesh:

Year:  2001        PMID: 11084232     DOI: 10.1016/s0169-2607(00)00083-3

Source DB:  PubMed          Journal:  Comput Methods Programs Biomed        ISSN: 0169-2607            Impact factor:   5.428


  3 in total

1.  Latent subgroup analysis of a randomized clinical trial through a semiparametric accelerated failure time mixture model.

Authors:  L Altstein; G Li
Journal:  Biometrics       Date:  2013-02-05       Impact factor: 2.571

2.  Amino acid sources in the adult diet do not affect life span and fecundity in the fruit-feeding butterfly Bicyclus anynana.

Authors:  Freerk Molleman; Jimin Ding; Jane-Ling Wang; Paul M Brakefield; James R Carey; Bas J Zwaan
Journal:  Ecol Entomol       Date:  2008-08       Impact factor: 2.465

3.  A population-based study on the effect of temozolomide in the treatment of glioblastoma multiforme.

Authors:  Pål A Rønning; Eirik Helseth; Torstein R Meling; Tom B Johannesen
Journal:  Neuro Oncol       Date:  2012-08-06       Impact factor: 12.300

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.